TGFB1 and allergic asthma: We also verified the hypothesis that the tested therapeutic strategies could induce the production of IL-10 and TGF-β (i.e., crucial anti-inflammatory and immunosuppressive cytokines) by Treg cells and thereby counteract the development of allergic asthma.